Richard Daly
Chief Executive Officer at CATALYST PHARMACEUTICALS, INC.
Net worth: 3 M $ as of 2024-03-30
Profile
Richard John Daly is the founder of Sagepath Partners LLC, which was founded in 2011.
He is currently the President, Chief Executive Officer & Director at Catalyst Pharmaceuticals, Inc. since 2015 and a Director at Andean Health & Development.
Mr. Daly has held various former positions including Chairman, President, Chief Executive Officer & CFO at Seneca Biopharma, Inc. from 2016 to 2018, Independent Director at Opiant Pharmaceuticals, Inc. from 2018 to 2023, Independent Director at Synergy Pharmaceuticals LLC from 2015 to 2018, Vice President-Commercial Strategy at TAP Pharmaceutical Products, Inc. from 2006 to 2008, Executive Vice President at Takeda Pharmaceuticals U.S.A., Inc. from 1998 to 2011, Chief Operating Officer at BeyondSpring Pharmaceuticals, Inc. from 2018 to 2022, Chief Operating Officer at BeyondSpring, Inc. from 2016 to 2022, Partner at Ravine Rock Partners LLC from 2014 to 2016, President at CARsgen Therapeutics Corp from 2022 to 2023, and President-US Diabetes at AstraZeneca LP from 2013 to 2014.
Mr. Daly received an undergraduate degree from the University of Notre Dame in 1983 and an MBA degree from Kellogg School of Management in 1998.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-14 | 212,147 ( 0.18% ) | 3 M $ | 2024-03-30 |
Richard Daly active positions
| Companies | Position | Start |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Chief Executive Officer | 2023-12-31 |
| Andean Health & Development | Director/Board Member | - |
Former positions of Richard Daly
| Companies | Position | End |
|---|---|---|
CARsgen Therapeutics Corp
 CARsgen Therapeutics Corp BiotechnologyHealth Technology CARsgen Therapeutics Corp is based in San Diego, CA. Part of CARsgen Therapeutics Holdings Ltd., CARsgen Therapeutics Corp is a biopharmaceutical company focused on innovative car t-cell therapies for the treatment of hematologic malignancies and solid tumors. The company has built an integrated cell therapy platform with in-house capabilities that span target discovery, antibody development, clinical trials, and commercial-scale manufacturing. | President | 2023-04-30 |
| OPIANT PHARMACEUTICALS, INC. | Director/Board Member | 2023-03-01 |
| BEYONDSPRING INC. | Chief Operating Officer | 2021-12-31 |
BeyondSpring Pharmaceuticals, Inc.
 BeyondSpring Pharmaceuticals, Inc. BiotechnologyHealth Technology Part of BeyondSpring, Inc., BeyondSpring Pharmaceuticals, Inc. is a clinical-stage bio-pharmaceutical company that develops innovative immuno-oncology cancer therapies. The private company is based in New York, NY. The company has a robust pipeline from internal development and collaboration with the University of Washington in de novo drug discovery using a ubiquitination platform. The CEO of the company is Lan Huang. | Chief Operating Officer | 2021-12-31 |
| PALISADE BIO, INC. | Chief Executive Officer | 2018-08-05 |
Training of Richard Daly
| University of Notre Dame | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CATALYST PHARMACEUTICALS, INC. | Health Technology |
| BEYONDSPRING INC. | Health Technology |
| Private companies | 11 |
|---|---|
Opiant Pharmaceuticals, Inc.
 Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
TAP Pharmaceutical Products, Inc.
 TAP Pharmaceutical Products, Inc. Pharmaceuticals: MajorHealth Technology TAP Pharmaceutical Products, Inc. manufactures, develops, and markets pharmaceutical products. Its services include gastroenterology, gynecology, and urology. The company was founded in 1977 and is headquartered in Lake Forest, IL. | Health Technology |
Seneca Biopharma, Inc.
 Seneca Biopharma, Inc. BiotechnologyHealth Technology Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD. | Health Technology |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The private company is based in Wilmington, DE. | Health Technology |
| Andean Health & Development | |
BeyondSpring Pharmaceuticals, Inc.
BeyondSpring Pharmaceuticals, Inc. BiotechnologyHealth Technology Part of BeyondSpring, Inc., BeyondSpring Pharmaceuticals, Inc. is a clinical-stage bio-pharmaceutical company that develops innovative immuno-oncology cancer therapies. The private company is based in New York, NY. The company has a robust pipeline from internal development and collaboration with the University of Washington in de novo drug discovery using a ubiquitination platform. The CEO of the company is Lan Huang. | Health Technology |
| Sagepath Partners LLC | |
| Ravine Rock Partners LLC | |
CARsgen Therapeutics Corp
CARsgen Therapeutics Corp BiotechnologyHealth Technology CARsgen Therapeutics Corp is based in San Diego, CA. Part of CARsgen Therapeutics Holdings Ltd., CARsgen Therapeutics Corp is a biopharmaceutical company focused on innovative car t-cell therapies for the treatment of hematologic malignancies and solid tumors. The company has built an integrated cell therapy platform with in-house capabilities that span target discovery, antibody development, clinical trials, and commercial-scale manufacturing. | Health Technology |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Richard Daly
